Rockefeller University

Digital Commons @ RU
Publications

Steinman Laboratory Archive

1999

Differentiation of phagocytic monocytes into lymph node
dendritic cells in vivo
Gwendalyn J. Randolph
Kayo Inaba
Davide E. Robbiani

Follow this and additional works at: https://digitalcommons.rockefeller.edu/steinman-publications

Immunity, Vol. 11, 753–761, December, 1999, Copyright 1999 by Cell Press

Differentiation of Phagocytic Monocytes
into Lymph Node Dendritic Cells In Vivo
Gwendalyn J. Randolph,*§ Kayo Inaba,‡
Davide F. Robbiani,* Ralph M. Steinman,†
and William A. Muller*
* Department of Pathology
Weill Medical College of Cornell University
† Laboratory of Cellular Physiology and Immunology
The Rockefeller University
New York, New York 10021
‡ Laboratory of Immunobiology
Department of Animal Development and Physiology
Kyoto University
Kyoto 606-8502
Japan

differentiate into DCs in an in vitro model of transendothelial trafficking without addition of exogenous cytokines (Randolph et al., 1998), supporting the idea that
monocytes can become DCs under physiologic conditions. Monocytes that mature to DCs in this model do so
most efficiently when they receive a phagocytic stimulus
during their transient residence in subendothelial matrix.
These nascent DCs then traffic across the endothelium
in the ablumenal-to-lumenal direction (Randolph et al.,
1998), a movement that may mimic the migration of
DCs from the periphery into the lumen of an afferent
lymphatic vessel. Prompted by these in vitro studies, we
have now employed murine models to address whether
monocytes become lymph-borne DCs in vivo after peripheral administration of phagocytic latex particles.

Summary
Results
We investigated the differentiation and trafficking of
inflammatory monocytes that phagocytosed subcutaneously injected fluorescent microspheres. As expected, most of the monocytes became microsphere1
macrophages, which remained in subcutaneous tissue. However, about 25% of latex1 cells migrated to
the T cell area of draining lymph nodes, where they
expressed dendritic cell (DC)-restricted markers and
high levels of costimulatory molecules. Microspheretransporting cells were distinct from resident skin
DCs, and this transport was reduced by more than
85% in monocyte-deficient osteopetrotic mice. Thus, a
substantial minority of inflammatory monocytes carry
phagocytosed particles to lymph nodes and differentiate into DCs.
Introduction
Monocytes continuously exit the bloodstream and enter
body tissues, where many differentiate to macrophages
(van Furth, 1988). Since there is no net accumulation of
macrophages in tissues during the steady state, monocyte entry into tissues may be just sufficient to replace
dying macrophages, or monocytes may only transiently
traverse tissues (van Furth, 1988). During resolution of
inflammation, at least some monocytes leave tissues by
migrating to draining lymph nodes (Bellingan et al.,
1996). However, the state of differentiation of monocytederived cells that arrive in lymph nodes has not been
characterized.
Human monocytes can be directed to develop into
potent immunostimulatory dendritic cells (DCs) when
cultured in the presence of GM-CSF and IL-4 (Sallusto
and Lanzavecchia, 1994; Bender et al., 1996; Kiertscher
and Roth, 1996; Romani et al., 1996; Zhou and Tedder,
1996), but it is not known whether monocytes encounter
physiologic conditions that induce their differentiation
to DCs in vivo. Recently, we observed that monocytes
§ To whom correspondence should be addressed (e-mail: gjrandol@

mail.med.cornell.edu).

Phenotype of Murine Phagocytic Cells at the Site
of Microsphere Injection
Intracutaneous injection of latex microspheres at various skin sites initiated the infiltration of monocytes (Figure 1A). By 18 hr following injection, essentially all particles had been phagocytosed by cells in the infiltrate.
Consistent with the possibility that these cells were
monocytes, the phagocytes expressed high levels of
CD11b (Springer et al., 1979) (Figure 1B) but were negative for the macrophage marker F4/80 (Hume et al., 1983)
at the time of infiltration. However, they upregulated
expression of F4/80 by day 3 (Figure 1C). Monocytes
express very low F4/80 antigen, but its expression increases during maturation to macrophages (Ajuebor et
al., 1998).
F4/80 and CD11b are also expressed on some interstitial DCs (Larsen et al., 1990; Weinlich et al., 1998). Thus,
to determine whether interstitial dermal DCs and/or epidermal DCs (Langerhans cells) had phagocytosed particles, skin sections were stained for expression of DEC205, a marker that identifies epidermal and dermal skin
DCs and many mature DCs in lymphoid organs (Kraal
et al., 1986; Inaba et al., 1995) but that is not expressed
on monocytes and macrophages. DEC-2051 cells very
rarely colocalized with microspheres, even though in
some sections a few DEC-2051 cells were observed in
tissue surrounding the microspheres (Figure 1D). Occasional DEC-2051 cells were seen bearing a very limited
number of particles, suggesting that some resident DCs
were modestly phagocytic in situ.
Fate of Phagocytes at the Site of Injection
In order to determine the fate of the injected microspheres, we performed acetone extraction of the tissue
at the site of microsphere injection and then quantitated
the units of fluorescence recovered. Approximately 25%
of injected microspheres were cleared from the skin by
day 4. The remaining 75% remained in situ. Histologic
analysis up to day 18 showed that such particles were
contained within a population of CD11b1F4/801DEC2052 macrophages (data not shown).
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Figure 1. Monocytes Ingest Latex Microspheres In Situ
FITC-dyed microspheres were injected intracutaneously into the dorsal thoracic skin.
Histologic and immunofluorescent analyses
were conducted at different time points. By
18 hr after injection of microspheres, a predominantly mononuclear cell infiltrate was
observed ([A], low power). Immunostaining
for cell surface markers (red) CD11b (B), F4/
80 (C), and DEC-205 (D) are shown from skin
sections collected after 18 hr (B and D) or 3
days (C) following injection of microspheres
([B–D], high power). These data are representative of more than a dozen experiments using several mouse strains. (A), (B), and (D)
show sections of skin from FVB/N mice, and
(C) is from mice of mixed background
(B6C3FEA/F1), which served as normal controls for the experiment using monocyte-deficient mutants shown in Figure 6C. Yellow
staining indicates colocalization of FITClabeled spheres (green) with Cy3-conjugated
mAb–labeled cells (red).

Previous work was consistent with the possibility that
some monocytes may leave tissues by retraversing the
vasculature (Randolph and Furie, 1996). Thus, we examined the blood and many body organs for the presence
of FITC-latex-bearing cells. Such cells were very rarely
observed in the spleen and were not detectable in the
blood (data not shown). However, a large population of
FITC-latex1 cells accumulated in draining lymph nodes,
reaching a maximum at 3–4 days (Figure 2A). Immunostaining for the B cell marker B220 to identify the follicles
within lymph nodes showed that particle-bearing cells
localized to the paracortical T cell area, just beneath the
B cell follicles (Figure 2B). Microsphere1 cells were rare
in the macrophage-rich subcapsular sinus or medulla
of the lymph nodes.
Control experiments were conducted, as previously

described (Harmsen et al., 1985), to ensure that we were
examining the trafficking of phagocytes from the periphery to draining lymph nodes rather than the possible
escape of free microspheres into afferent lymph and
subsequent uptake by cells already present in the lymph
node. Red fluorescent microspheres were injected into
a skin site adjacent to but not overlapping with the site
at which FITC-dyed microspheres had been injected.
The selected sites all drained to the same lymph nodes
(brachial). Cells that accumulated by day 4 in draining
lymph nodes contained either green or red microspheres,
but not both (Figure 2C), demonstrating that the particles
were engulfed by phagocytes in the tissues before they
migrated to the lymph node. Had the particles entered
lymph on their own, beads of both colors would have been
found together within individual cells in the lymph node.

Figure 2. Migration of Microsphere1 Cells to the T Cell Zone of Draining Lymph Nodes
Lymph node sections were examined daily up to 8 days. Peak accumulation of microspheres occurred at day 3–4 (A). Microsphere1 cells
localized to the T cell paracortical region that lies just beneath the B cell follicles, which were stained with B220 mAb followed by Cy3conjugated secondary mAb (B). Injection of green and red microspheres, respectively, at adjacent but nonoverlapping sites in skin showed
individual cells in the lymph node at day 4 that contained microspheres of one color or the other, but not both (C). Panel was photographed
during UV light excitation, such that green microspheres appear turquoise and red beads appear orange.

Differentiation of Monocytes into DC In Vivo
755

Figure 3. Cell Surface Phenotype of Microsphere1 Cells in the Lymph Node
Single-cell suspensions of the lymph nodes (day 3) were prepared and stained with mAbs to a number of cell surface markers, control mAb
KJ16, or no primary mAb (“None”). In other animals, latex was injected into the peritoneal cavities to compare the phenotype of lymph node
microsphere1 cells to peritoneal macrophages that engulfed beads during the 3 days following bead injection. Profiles have been gated on
microsphere1 cells. Log fluorescence of surface markers is indicated on the x axis; log fluorescence of ingested microspheres is indicated
on the y axis. Note the banding pattern of the microspheres, in which the first band of lowest fluorescence intensity represents cells containing
one bead per cell, the second band two beads per cell, and so on. The mean fluorescence intensity with respect to cell surface markers is
shown in the lower right of each profile.

Microsphere1 Cells in Lymph Node Exhibit a Cell
Surface Phenotype Resembling Dendritic Cells
DCs and T cells are abundant in the lymph node paracortex, whereas macrophages accumulate predominantly
in the subcapsular space and in the medulla. In agreement with the localization of bead1 cells in the paracortex, flow cytometric evaluation of lymph node cells revealed a population of latex-bearing cells that displayed
a cell surface phenotype that was consistent with DCs
(Inaba et al., 1997) and was clearly distinct from the
phenotype of mononuclear phagocytes recovered from
the peritoneal cavity of additional mice injected intraperitoneally three days earlier with microspheres (Figure 3).
Latex-containing lymph node cells expressed very high
levels of MHC class I and II and the T cell costimulatory
molecule CD86, but they were not B cells, as illustrated
by a lack of B220. There was little to no expression of the
T cell marker CD8a, which in mice identifies lymphoid
DCs (Shortman and Caux, 1997). Microsphere1 cells
expressed a number of molecules restricted to DCs,
including the MIDC-8 (Breel et al., 1987) and 2A1 (Inaba
et al., 1992) antigens. A fraction of these cells also expressed DEC-205.
The flow cytometric analysis permitted an evaluation
of phagocytic activity. Because the polystyrene particles were uniformly fluorescent, a banding pattern with
respect to cell-associated fluorescence was observed.
The band of least fluorescence intensity corresponded

to cells that ingested a single microsphere, and the next
band of cells with double the fluorescence intensity of
the first band contained two microspheres, etc. Cells
that had ingested a single microsphere showed expression of the DC marker CD11c, whereas cells with three
or more particles had little or no CD11c. All together,
these data suggest that particle-bearing cells in the
lymph node are CD11cdim DCs, not macrophages.
Microsphere1 Cells Do Not Originate
from Langerhans Cells
Migration of Langerhans cells is stimulated by epicutaneous application of contact sensitizers (Kripke et al.,
1990). Soluble FITC serves as contact sensitizer, and
FITC-labeled cells can be recovered in the draining
lymph node (Kripke et al., 1990). FITC1 lymph node cells
appear to be derived entirely from the Langerhans cell
population (Sato et al., 1998). When we utilized this
model, we observed that all FITC1 cells in the lymph
node were CD11c1 (Figure 4, upper left). To test whether
microsphere-bearing DCs in the lymph node originated
from Langerhans cells or other cells such as monocytes,
we injected red fluorescent microspheres intracutaneously either 8 hr prior to or coincident with topical application of solubilized FITC. As analyzed by two-color
flow cytometry, the microsphere-containing cells in the
lymph node were distinct from the FITC1 cells (Figure 4),
indicating that the vast majority of microsphere1 lymph
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Figure 4. Bead1 Lymph Node Cells Do Not Coincide with Langerhans Cells that Migrate to Lymph Nodes in Response to a Contact
Sensitizer
Red fluorescent microspheres were injected intracutaneously 8 hr
prior to (y axis “Red Beads”, 28 hr) or coincident (y axis “Red
Beads”, 0 hr) with the topical application of soluble FITC, which
acts as a contact sensitizer. In some mice, only red beads were
injected or only FITC was applied without injection of beads. Total
lymph node cells were analyzed by flow cytometry 2 days later. In
a sample in which only FITC was applied, lymph node cells were
double stained for CD11c expression (upper left panel). For twocolor analysis with beads and soluble FITC, the extreme brightness
of the red beads in the FL2 channel made establishing voltage
and compensation parameters difficult. Nevertheless, the two colors
could be distinguished. Data shown are derived from one of three
independent experiments conducted that show similar results.

node DCs do not originate from Langerhans cells. Only a
few single bead-containing cells may also have acquired
soluble FITC (Figure 4).
Characterization of Bead1 Cells that Emigrate from
Skin Explants in the Presence and Absence
of Inflammatory Monocytes
Using an ex vivo model of cellular migration via lymphatics, we tested further whether a subset of inflammatory
monocytes, rather than resident skin DCs, served as
precursors for particle-laden lymph node DCs. Previous
research has shown that DCs and T lymphocytes migrate out of cultured mouse ear explants (Larsen et
al., 1990; Ortner et al., 1996) by entering the lymphatic
vessels (Weinlich et al., 1998). To investigate the phagocytic capacity and phenotype of cells that emigrated
from inflamed skin, microspheres were injected into the
intracutaneous tissue of mouse ears 18 hr prior to sacrifice and preparation of ear explants. Thus, ear tissue
from the mice would contain inflammatory monocytes.
Alternatively, phagocytic activity and migration of resident dermal and epidermal DCs in the absence of inflammatory monocytes were studied by injecting the
microspheres into the skin just following sacrifice. A
population of microsphere1 cells was observed under
both conditions. However, the microsphere1 MHC IIhi
cells that migrated from noninflamed skin had phagocytosed fewer particles per cell than emigrés collected
from cultures containing inflammatory cells (Figure 5A).
Interestingly, nonphagocytic DCs and those ingesting
only 1–2 beads per cell expressed CD11c (Figure 5A)
typical of dermal DCs and Langerhans cells. In contrast,

the more phagocytic MHC IIhi cells that appeared only in
explants containing inflammatory cells did not express
CD11c or were CD11cdim (Figure 5A, bracket). Likewise,
only some of the bead1 cells in the lymph node expressed CD11c, and those expressing the highest levels
tended to be the least phagocytic (Figure 3). These
bead1 MHC IIhi cells were derived from cells that did not
express MHC II when they first acquired the microparticles, because bead1 cells within the skin did not express MHC II (Figure 5B) except for an occasional dermal
DC that had ingested a single particle (arrowhead, Figure
5B). The number of microsphere1 DCs was approximately four times higher from explants containing inflammatory cells, with the majority of the increased emigration occurring in the first 2 days of culture. These data
suggest that monocytes recruited during inflammatory
reactions give rise to a population of microsphere-bearing CD11cdimMHC IIhi DCs.
To study the immunostimulatory potential of microsphere-bearing cells, we first attempted to isolate
bead1 cells from the lymph node, mainly by using paramagnetic microspheres and corresponding isolation
protocols. However, we were unable to isolate them to
sufficient purity and yield, probably because these cells
represented only about 2% of lymph node DCs, or approximately 0.04% of total lymph node cells. Because
bead1 cells that migrated from the skin explants, apparently via lymphatics, are naturally enriched for DCs, we
could successfully sort these cells by flow cytometry.
Sorting for cells that expressed high levels of MHC II,
microsphere1 cells derived from inflamed ear explants
were isolated and cultured with allogeneic T cells. We
sorted microsphere1 cells that had phagocytosed more
than one particle per cell. Bead1 emigrés from inflamed
mouse ears induced robust proliferation (counts per
minute at 1 bead1 cell per 300 T cells) of allogeneic T cells
to a somewhat higher but generally similar degree as
the nonphagocytic population of DCs that also migrated
out of the explants (Figure 5C). We cannot eliminate the
possibility that a few phagocytic resident DCs (such as
dermal DCs) contaminated our sorted preparation. The
number of CD11c1bead1 cells was less than 5% of the
total MHC II1bead1 cells in the inflammatory cell population, suggesting that such contamination was minimal.
Characterization of Microsphere Transport to
Lymph Nodes in Monocyte-Deficient Mice
To extend our investigation into the possibility that the
more phagocytic CD11cdim MHC IIhi cells that emigrated
from skin to the draining lymph nodes were DCs derived
from monocytes, we studied DC-mediated lymphatic
transport of microspheres in monocyte-deficient mice.
Osteopetrotic mice (op/op) harbor a null mutation in the
M-CSF (CSF-1) gene and therefore are severely deficient
in monocytes and many populations of tissue macrophages (Wiktor-Jedrzejczak et al., 1982). Previously
characterized, monocyte-independent populations of
DCs are intact in these mice (Witmer-Pack et al., 1993),
and we observed normal migration of DCs from noninflamed ear explants (Langerhans cells and dermal DCs)
established from op/op and normal littermates (data not
shown). Thus, these mice permitted the analysis of
monocyte-derived DCs without apparent absence or
dysfunction among other DC subsets.
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Figure 5. Phagocytic Load, Phenotype, and Allostimulatory Capacity of Cells that Emigrated from Dermal Lymphatics of Inflamed and Noninflamed Skin
(A) Microspheres were injected into the intracutaneous tissue of mouse ears 18 hr prior to (“1 Inflammatory Infiltrate”) or at the time of sacrifice
(“No Inflammatory Infiltrate”). The former condition permits the influx of inflammatory cells, but the latter does not and therefore would allow
microsphere uptake only by resident Langerhans cells or interstitial DCs and macrophages. Explants of the dorsal leaflet of the ears were
cultured for five days, with transfer to fresh medium daily. Data shown are cells that emigrated between the first and second day of culture,
when DCs derived from inflammatory cells were particularly abundant. Flow cytometric evaluations show isotype-matched control mAb, antiCD11c mAb, and anti-MHC II mAb. Data are representative of five independent experiments.
(B) Skin sections were examined for expression of MHC II. Most inflammatory bead1 cells (green) did not express MHC II (red), and resident
MHC II1 cells contained only a single or no microspheres (arrowhead).
(C) Microspheres were injected into the intracutaneous tissue of mouse ears 18 hr prior to sacrifice and establishment of ear explant cultures.
Emigrated cells from the second day of these cultures were stained with PE-conjugated anti-MHC II mAb and sorted by flow cytometry for
MHC IIhi expressing cells lacking microspheres (“No Beads”) and those containing more than a single microsphere (“1 Beads”). For analysis
of allogeneic T cell proliferation, the sorted cells were mixed with allogeneic CD41/CD81 splenic and lymph node T cells at a ratio of 5 3 102
sorted cells/1.5 3 105 T cells. DNA synthesis was measured at 66–72 hr.

A very limited to absent inflammatory reaction was
observed in op/op mice at the site of microsphere injection, as observed by histologic evaluation (Figures 6A
and 6B) and the relative paucity of F4/801 cells that
were present (Figure 6C, compare to Figure 1C). These
scattered F4/801 resident dermal macrophages, which
represent one of the few macrophage populations found
in op/op mice (24), phagocytosed numerous microspheres (Figure 6C, yellow). Dermal DCs were present in
these mice, but just as observed in wild-type and op/1
littermates, DEC-2051 DCs (red) did not colocalize with
FITC microspheres (Figure 6D).
Particle transport to lymph nodes by DCs in op/op
mice and normal littermates (op/1 or 1/1) was compared. Normal (op/1) mice possessed a population of
lymph node MHC IIhi2A11 paracortical DCs that contained three or more microspheres per cell (Figure 6E,
arrows), but op/op mice essentially lacked this population (Figures 6F and 6G). However, like their normal counterparts, op/op lymph nodes contained a population of
DCs associated with a single microsphere per cell. As
in previous experiments (Figures 3 and 5), only these
modestly phagocytic cells (1 bead/cell) were CD11c1
(data not shown).
Discussion
Questions regarding the ontogenic relationship of DCs
with monocytes and macrophages have been longstanding. When tissues are broadly surveyed by immunohistochemistry for DC number and organization, only

slight differences are observed between normal mice
and monocyte-deficient op/op mice (Witmer-Pack et al.,
1993), leading to the conclusion that most DCs do not
derive from monocytes. However, using these mutant
mice, we have conducted assays that highlight the existence of a subpopulation of monocyte-derived DCs.
These cells express high levels of MHC II, CD86, and
DC-restricted markers 2A1 and MIDC-8 and localize to
the T cell area of lymph nodes. In contrast to other
murine DCs, there is little to no expression of CD11c, and
only some express DEC-205. These monocyte-derived
DCs exhibit the highest phagocytic capacity among peripheral DC subsets. The phagocytic activity of these
cells is reminiscent of the phagocytic rat lymph-borne
DCs previously reported (Matsuno et al., 1996), suggesting that such DCs may also be derived from monocytes.
In addition, a population of DCs that had ingested
only 1–2 microspheres per cell migrated out of skin explants and was observed in lymph nodes. The appearance of these cells in draining lymph nodes was not
affected by the presence or absence of monocytes. Very
few of these cells appear to be derived from Langerhans
cells, but occasional single bead1 cells were observed
in the dermis. Thus, it is likely that these modestly
phagocytic cells are dermal DCs.
Several past studies have traced the trafficking of
particles from the periphery to draining lymph nodes,
and it has been shown that such trafficking is mediated
by mononuclear phagocytes (Harmsen et al., 1985). Indeed, data obtained in these studies (Smith et al., 1970;
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Figure 6. Phagocytic Load and Phenotype of Lymph Node DCs in Monocyte-Deficient Mice or Normal Littermates
FITC-latex microspheres were injected into the ear tissue and/or footpads of 5-week-old op/1 mice or op/op mutants. The former exhibited
a vigorous inflammatory response to the injection (A), but the latter did not (B–D). After 3 days, the local cellular response was evaluated at
the site of injection by examining frozen sections histologically and immunostaining for macrophages using F4/80 (C) and DCs using antiDEC-205 mAbs (D), respectively. The micrograph of F4/80 staining (red, [C]) shows a few large resident macrophages in op/op mice that stain
yellow (green latex 1 red F4/80; compare with op/1 mice in Figure 1C), whereas the area shown for DEC-2051 cells (red) represents an area
with a somewhat higher abundance of DCs than is typical for either mutant or control littermates. Sections of draining lymph nodes collected
at day 3 from op/1 (E) and op/op (F) mice were stained for the DC marker 2A1. 2A11 cells containing only one microsphere are highlighted
by arrowheads. 2A11 cells that had ingested numerous microspheres are evident in sections of op/1 lymph nodes (arrows) but not op/op
lymph nodes. (G) Single-cell suspensions from op/1 and op/op lymph nodes were prepared, and MHC IIhi labeled cells were evaluated by
flow cytometry to determine the number of microsphere1 DCs per lymph node and the extent of their phagocytic load. Data show the averaged
results from two independent experiments that were conducted using two 5-week-old mice per experiment. The graph illustrates the mean
number of microsphere1 DCs recovered from the pooled brachial lymph nodes of individual mice, and the particle content of these cells is
plotted as one bead/cell (“1”), two beads/cell (“2”), and three or more beads/cell (“31”).

Yamashita et al., 1978; Corry et al., 1984; Harmsen et
al., 1985; Hardonk et al., 1986; Bellingan et al., 1996) are
consistent with our findings. However, previous work
assumed that particle-bearing cells in the lymph node
were macrophages without a comprehensive analysis
of cell surface phenotype, localization within the lymph
node, or function. Thus, we were surprised to discover
that few particle-bearing cells in the lymph node were
macrophages, but that instead these cells were DCs.
Importantly, our experiments were designed to exclude
conditions in which particles may enter lymph without
involving active cellular transport. Some previous studies examined cellular transport from the peritoneal cavity (Rosen and Gordon, 1990; Bellingan et al., 1996).
When we performed experiments by injecting microspheres into the peritoneal cavity, we observed that in
contrast to skin injections, both DCs and subcortical
macrophages became heavily laden with microspheres

(data not shown). Thus, the pattern of particle drainage
from the peritoneal cavity appears to be different from
other body tissues. Possibly, the lymphatics of the peritoneal cavity are relatively leaky, allowing a higher level
of passive translocation of microspheres not seen in
other anatomic sites. Passive particle translocation may
also have occurred in previous studies that used very
small carbon particles instead of the larger particles
used herein, thereby explaining the strong macrophage
labeling in those studies (Cohen et al., 1966; Fossum,
1980).
Particulate antigens are thought to be among the
most potent inducers of immunity (Raychaudhuri and
Rock, 1998). When soluble antigen is administered with
Freund’s adjuvant to op/op mice, the resulting immune
response appears similar to that mounted in their normal
counterparts (Wiktor-Jedrzejczak et al., 1992; Chang et
al., 1995). However, immunity to the particulate micro-
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bial antigen, Mycobacterium tuberculosis, is dramatically diminished in op/op mice, such that the mice succumb rapidly (Teitelbaum et al., 1999). Importantly, colony forming units corresponding to the spread of
tubercle bacilli fail to accumulate in draining lymph
nodes (Teitelbaum et al., 1999). Combining such observations with our studies, it seems that the acquisition
and presentation of particulate antigens may define a
major role for DCs derived from monocytes. Thus, immune responses to antigens acquired by phagocytosis
would likely be enhanced by the recruitment of monocytes and rapid clearance from peripheral tissues as
they differentiate into DCs.
Approaches to promote regression of atherosclerotic
lesions, which are replete with lipid-laden macrophages,
are still a major clinical challenge. The present findings
suggest that monocyte-derived macrophages remain
predominantly in the periphery and that monocytes that
become DCs readily migrate to the lymph node. This
observation is in agreement with our in vitro transendothelial trafficking model, in which human monocytederived DCs reverse transmigrate but macrophages remain in the subendothelial tissue (Randolph et al., 1998).
Our data underscore the possibility that an increase
in DC development from monocytes could lead to the
clearance of monocyte-derived cells from tissues in
chronic disorders in which macrophage accumulation
is excessive and pathologic, as in atherosclerosis. Additional studies are needed to investigate the mechanism(s) that regulate the commitment and differentiation
of monocytes to macrophages versus DCs in situ.
Experimental Procedures
Mice
A variety of strains were employed in these experiments, with similar
results. Most experiments used female mice at 8 weeks of age.
Strains CD1 and CD2/F1 were purchased from Charles River Labs,
and strains FVB/N and C57BL/6 were purchased from Jackson Labs
or were bred in our own facilities. Heterozygous breeders (B6C3FEA/
F1 background) for the osteopetrotic mutation (op) were purchased
from Jackson Labs. Op/op mutants were recognized by their smaller
size and lack of teeth and were maintained on a diet of powdered
chow supplemented with daily feedings of Enfamil (Chang et al.,
1995). Mutants and normal littermates were used in experiments at
5 weeks of age, before the mutant phenotype begins to be corrected
by the M-CSF-like activity of vascular endothelial cell growth factor
(Niida et al., 1999). At this time, the average weight of the mutants
was 9 g, compared with about 20 g for the op/1 and 1/1 controls.
Injection of Microspheres
All protocols were approved by institutional animal review committees at The Rockefeller University and Weill Medical College of
Cornell University. For injection, microspheres of 0.5 or 1.0 mm in
diameter were resuspended to 0.0025% or 0.025% (w/v) in PBS.
Preparations of these microspheres lacked detectable levels of LPS,
using the Limulus detection system from Cape Cod Associates.
Mice were anesthetized by inhalation of Metofane (Schering-Plough)
and injections were administered into the intracutaneous tissue of
the front or rear footpads (10 and 25 ml, respectively). Alternatively,
intracutaneous injections were made at shaved areas of the dorsal
thoracic skin or into the intracutaneous tissue of the ear (10 ml/
injection). All injections were made with Hamilton syringes (Fisher).
Similar results were obtained using FITC-dyed polystyrene (FITClatex) or carboxy-modified microspheres that fluoresce in the red
range (488 nm/605 nm; Molecular Probes). In other experiments,
microspheres were injected into the peritoneal cavity. At times indicated (typically 3 days) following microsphere injection, mice were

sacrificed by CO2 inhalation and lymph nodes were collected. The
front footpad and dorsal thoracic skin drain to the brachial lymph
nodes, the rear footpad to the popliteal nodes, and the peritoneal
cavity to the parathymic lymph nodes (Tilney, 1971).
Acetone Extractions
Skin surrounding the site of injection was excised and frozen at
2208C until all time points were collected. Thawed skin samples
were immersed in 500 ml of acetone to dissolve the polystyrene
microspheres and allowed to soak for at least 1 hr. Then the tissue
was crushed in a Dounce homogenizer. The supernatant was mixed
with H20 at a 1:1 ratio, and the fluorescence in a 100 ml aliquot was
read using a Cytofluor 2350 fluorescence measurement system from
PerSeptive Biosystems.
Topical Application of Soluble FITC
FITC was dissolved in acetone/dibutylphthalate and applied to the
shaved dorsal thoracic skin of mice according to the “low dose”
procedure previously described (Gunn et al., 1999).
Ear Explant Cultures
Microspheres were injected at three locations per ear (10 ml each)
either 18 hr before or just after sacrifice of the mice. Ears were then
resected and cultured as previously described, with transfer of the
explants to fresh medium daily (Ortner et al., 1996).
Immunostaining
Skin or lymph nodes were snap-frozen in OCT compound (Miles),
and 10 mm sections were prepared and affixed to polylysine-coated
slides. Sections were fixed in freshly prepared 3% neutral-buffered
paraformaldehyde for 5 min, rinsed in PBS, and blocked with 0.2%
chicken ovalbumin plus 5% normal serum for 10 min. Sequential
mAb incubations were for 45 min each, with mAb incubations separated by three washes in PBS. Primary antibodies used included
anti-DEC-205 mAb NLDC 145 (Cedarlane), biotinylated anti-F4/80
mAb (Serotec), F4/80 supernatant (Biosource International), 2A1 supernatant, anti-CD11b mAb 5C6, anti-CD11c supernatant N418,
anti-B220 mAb (Cedarlane), anti-CD4 mAb (PharMingen), biotinylated anti-MHC II mAb, and purified rat IgG2a (PharMingen). Cy3conjugated donkey anti-rat mAb (Jackson Immunoresearch) or Cy3conjugated strepavidin (Sigma) was used for detection.
Flow Cytometry
Flow cytometric staining and analysis was conducted as previously
described (Inaba et al., 1992). Anti-MHC II mAb M5/114.15.2 and
KJ16 were from the American Type Culture Collection; mAbs to
CD8, CD11b, CD11c, CD86, and B220 were purchased from PharMingen, and mAb 2A1 was generated in this laboratory. Anti-DEC205 (NLDC 145) and MIDC-8 mAbs were kindly provided by Dr.
George Kraal (Amsterdam). To detect the intracellular epitopes recognized by 2A1 and MIDC-8, cells were fixed and permeabilized as
described (Inaba et al., 1992).
Mixed Leukocyte Reaction
Following injection of microspheres 18 hr prior to sacrifice and establishment of ear explant cultures, DCs that emigrated between
24 and 48 hr of culture from 40 ear explants were pooled, stained
with anti-MHC II mAb, and sorted. Gates were set to collect MHC
II1 cells with 0–1 beads/cell or $2 beads/cell. The cell fractions
recovered were incubated with 3 3 105 allogeneic T cells/well. T
cells were purified from pooled splenic and lymph node cells that
had been depleted of MHC II–expressing cells by treatment with
rat anti-MHC II mAb followed by anti-rat magnetic beads (Dynal).
Candidate antigen-presenting cells were mixed with T cells at indicated ratios, cultured for 3–4 days, and finally cultured in [3H]thymidine (4 mCi/ml) for 13 hr.
Acknowledgments
We are grateful to Hongli Li and Petra Hänel for expert technical
assistance, to Frank Isdell and Dr. Regis Josien for advice and help
with flow cytometry, and to Dr. Maggi Pack for advice on preparation
of frozen sections and immunostaining. This work was supported

Immunity
760

by a National Institutes of Health National Research Service Award
(HL09722) and American Heart Association (AHA) Scientist Development Grant (9930118N) to G. J. R., an award from De Bernardi
Foundation of Bern Medical School (Switzerland) to D. F. R., and
grants from the National Institutes of Health to R. M. S. (AI 13013)
and W. A. M. (HL 46849). W. A. M. is an Established Investigator of
the AHA.
Received September 9, 1999; revised November 8, 1999.
References
Ajuebor, M.N., Flower, R.J., Hannon, R., Christie, M., Bowers, K.,
Verity, A., and Perretti, M. (1998). Endogenous monocyte chemoattractant protein-1 recruits monocytes in the zymosan peritonitis
model. J. Leukoc. Biol. 63, 108–116.
Bellingan, G.J., Caldwell, H., Howie, S.E.M., Dransfield, I., and Haslett, C. (1996). In vivo fate of the inflammatory macrophage during
the resolution of inflammation. J. Immunol. 157, 2577–2585.
Bender, A., Sapp, M., Schuler, G., Steinman, R.M., and Bhardwaj,
N. (1996). Improved methods for the generation of dendritic cells
from nonproliferating progenitors in human blood. J. Immunol. Methods 196, 121–135.
Breel, M., Mebius, R.E., and Kraal, G. (1987). Dendritic cells of the
mouse recognized by two monoclonal antibodies. Eur. J. Immunol.
17, 1555–1559.
Chang, M.Y., Stanley, E.R., Khalili, H., Chisholm, O., and Pollard,
J.W. (1995). Osteopetrotic (op/op) mice deficient in macrophages
have the ability to mount a normal T-cell-dependent immune response. Cell. Immunol. 162, 146–152.
Cohen, S., Vassalli, P., Benacerraf, B., and McCluskey, R.T. (1966).
The distribution of antigenic and nonantigenic compounds within
draining lymph nodes. Lab. Invest. 15, 1143–1155.
Corry, D., Kulkarni, P., and Lipscomb, M.F. (1984). The migration of
bronchoalveolar macrophages into hilar lymph nodes. Am. J. Pathol.
115, 321–328.
Fossum, S. (1980). The architecture of rat lymph nodes. Scand. J.
Immunol. 12, 433–441.
Gunn, M.D., Kyuwa, S., Tam, C., Kakiuchi, T., Matsuzawa, A., Williams, L.T., and Nakano, H. (1999). Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J. Exp. Med. 189, 451–460.

cells, veiled cells, and interdigitating cells in the mouse recognized
by a monoclonal antibody. J. Exp. Med. 163, 981–997.
Kripke, M.L., Munn, C.G., Jeevan, A., Tang, J.M., and Bucana, C.
(1990). Evidence that cutaneous antigen-presenting cells migrate to
regional lymph nodes during contact sensitization. J. Immunol. 145,
2833–2838.
Larsen, C.P., Steinman, R.M., Witmer-Pack, M., Hankins, D.F., Morris, P.J., and Austyn, J.M. (1990). Migration and maturation of Langerhans cells in skin transplants and explants. J. Exp. Med. 172,
1483–1493.
Matsuno, K., Ezaki, T., Kudo, S., and Uehara, Y.A. (1996). A life stage
of particle-laden rat dendritic cells in vivo: their terminal division,
active phagocytosis, and translocation from the liver to the draining
lymph node. J. Exp. Med. 183, 1865–1878.
Niida, S., Kaku, M., Amano, H., Yoshida, H., Kataoka, H., Nishikawa,
S., Tanne, K., Maeda, N., Nishikawa, S.-I., and Kodama, H. (1999).
Vascular endothelial growth factor can substitute for macrophage
colony-stimulating factor in the support of osteoclastic bone resorption. J. Exp. Med. 190, 293–298.
Ortner, U., Inaba, K., Koch, F., Heine, M., Miwa, M., Schuler, G.,
and Romani, N. (1996). An improved isolation method for murine
migratory cutaneous dendritic cells. J. Immunol. Methods 193,
71–79.
Randolph, G.J., and Furie, M.B. (1996). Mononuclear phagocytes
egress from an in vitro model of the vascular wall by migrating
across endothelium in the basal to apical direction: role of intercellular adhesion molecule 1 and the CD11/CD18 integrins. J. Exp. Med.
183, 451–462.
Randolph, G.J., Beaulieu, S., Lebecque, S., Steinman, R.M., and
Muller, W.A. (1998). Differentiation of monocytes into dendritic cells
in a model of transendothelial trafficking. Science 282, 480–483.
Raychaudhuri, S., and Rock, K.L. (1998). Fully mobilizing host defense: building better vaccines. Nat. Biotechnol. 16, 1025–1031.
Romani, N., Reider, D., Heuer, M., Ebner, S., Kämpgen, E., Eibl,
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